Skin patch T-cell Covid vaccine to be trialled in Switzerland
A British biotech firm is set to start clinical trials in Switzerland of a skin patch vaccine against Covid-19 that uses T-cells and could offer longer-lasting immunity than existing vaccines.
This content was published on
2 minutes
The Guardian/swissinfo/sb
Español
es
Suiza someterá a prueba vacuna COVID en parche cutáneo
Emergex announcedExternal link on Monday that it had received the green light from the Swiss drugs regulator to carry out initial human trials in Lausanne, starting January 3, 2022.
The company’s easy-to-administer skin patch vaccine primes T-cells – a group of immune cells that can target and destroy virus-infected cells – to remove infected cells from the body quickly after infection, thus preventing viral replication and disease.
Robin Cohen, Emergex’s chief commercial officer, told The GuardianExternal link newspaper: “This is the first time a regulator has approved a Covid vaccine to go into clinical trials whose sole purpose is to generate a targeted T-cell response in the absence of an antibody response and those T-cells look for infected cells and kill them.”
Current Covid-19 vaccines mainly generate an antibody response that wanes over time, which means people need booster shots to maintain protection against the virus. The Emergex vaccine works differently, by killing infected cells quickly. This means it could offer longer-lasting immunity – possibly for decades – and could also be better at fighting virus mutations, said Cohen.
The trial will be conducted by Blaise Genton, a professor at the University of Lausanne’s centre for primary care and public health. He said: “This exciting new scientific approach to developing a vaccine against Sars-CoV-2 addresses the need to generate a T-cell response to elicit long-term immunity.”
In all, 26 people will receive a high and a low dose of its experimental Covid-19 vaccine. Interim results from the trial are expected in June.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Three people arrested in Switzerland in international drug gang crackdown
This content was published on
International co-operation led to 17 people being arrested in six European countries and large quantities of drugs also being seized.
Federal Council banks on R&D to strengthen Swiss solar industry
This content was published on
The Swiss government opposes the deployment of special industrial policy or measures to help boost the domestic photovoltaic industry.
Swiss president envisions follow-ups to peace summit
This content was published on
Swiss President Viola Amherd hopes the first Ukraine peace conference will build trust and seek solutions for safety and security issues.
This content was published on
With use of drugs such as crack on the rise, the government wants to invest in additional facilities for people suffering from addiction.
Alleged French spy tied to Swiss NGO arrested in Russia
This content was published on
The man, who Russia has claimed was trying to obtain information about the Russian military, was confirmed to be a French citizen working for a Geneva-based NGO.
This content was published on
Plaintiffs in a class-action lawsuit are claiming that Switzerland prioritised national interest over its legal obligation to bondholders.
This content was published on
Most Swiss people are planning at least one holiday this year in spite of rising costs and inflation, according to a study.
Italian busted smuggling alcohol in milk and shampoo bottles into Switzerland
This content was published on
An Italian motorhome driver has been caught trying to smuggle 135 litres of pure alcohol disguised in various bottles into Switzerland.
While Switzerland struggles to vaccinate, Portugal is already finished
This content was published on
Nowhere are more people vaccinated against Covid-19 than in Portugal, where 98% of over 25-year-olds have had both doses.
Vaccine alternative has limited impact on Covid campaign
This content was published on
The offer of a non-mRNA Covid vaccine in Switzerland has failed to speed up the government’s vaccination campaign, experts say.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.